Stephen Silvestri is the Chief Executive Officer of OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health platform that connects pharmaceutical companies with healthcare providers to improve patient outcomes through targeted messaging and engagement solutions. With more than 20 years of experience in technology leadership, SaaS platforms, and digital transformation, Silvestri joined OptimizeRx in 2017 as Chief Operating Officer, advanced to President in 2018, and assumed the CEO role in 2020. His strategic oversight has positioned the company as a pioneer in point-of-care digital communications, serving over 5,000 healthcare providers and partnering with major biopharma organizations. Prior to OptimizeRx, Silvestri held senior executive roles at CDK Global, including Senior Vice President of Product Management, where he drove innovative SaaS solutions for the automotive industry, managing multimillion-dollar portfolios and leading cross-functional teams to deliver scalable digital products. His earlier career at Cox Automotive and other tech firms further solidified his expertise in customer acquisition, product innovation, and revenue optimization. Key achievements include overseeing OptimizeRx's revenue growth from $35 million in 2019 to over $110 million by 2023, completing strategic acquisitions like DoseSpot and the Med Ad News portfolio, and navigating the company through a successful public market expansion. As CEO, Silvestri continues to champion data-driven technologies that enhance medication adherence and patient engagement, fostering collaborations that bridge gaps in healthcare delivery. His visionary leadership has earned industry recognition, including OptimizeRx's consistent ranking among top digital health innovators, while steering the company toward AI-enhanced solutions and expanded global reach.